Skip to main content
OpenTrials
Completed

NCT Number: NCT05202470

Effectiveness of Telehealth Program in Patients With Type 2 Diabetes

Diabetes education is of great importance in the effective management of diabetes. Studies have shown that patients given diabetes education have positive developments in their ability to manage the disease and their attitudes towards the disease. The aim of the study is to compare the education given to individuals with Type 2 diabetes via mobile phone and the education given to individuals via brochures with conventional methods.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Type 2 Diabetes Diabetes Mellitus Diabetes Mellitus, Type 2 Endocrine System Diseases Glucose Metabolism Disorders Metabolic Diseases Nutritional and Metabolic Diseases

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Muğla Training and Research Hospital

Muğla, 48000, Turkey (Türkiye)

About this study

The use of telehealth technologies in the field of health is becoming more and more widespread. Telehealth has become one of the frequently used options in the follow-up process of chronic diseases such as diabetes, especially in recent years. Diabetes education is of great importance in the effective management of diabetes. Studies have shown that patients given diabetes education have positive developments in their ability to manage the disease and their attitudes towards the disease. The aim of the study is to compare the education given to individuals with Type 2 diabetes via mobile phone and the education given to individuals via brochures with conventional methods.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Having a diagnosis of type 2 diabetes mellitus for at least 6 months,
  • Those between the ages of 18-65,
  • Receiving oral antidiabetic and/or insulin therapy,
  • Having a mobile phone capable of receiving and playing video messages,
  • Does not have hearing, speech and psychiatric problems that prevent communication,

Exclusion criteria

  • Individuals who do not volunteered to participate in the study
  • Patients who have hearing, speech and psychiatric problems that prevent communication

Treatment and study plan

TE

Other

After the first meeting, diabetes education videos prepared in two parts a week will be sent to the mobile phones of the individuals. The video submission will be completed in a total of four weeks.

CE

Other

After the first meeting, diabetes education videos prepared in two parts a week will be sent to the mobile phones of the individuals. The video submission will be completed in a total of four weeks.

Primary outcomes

  1. International Survey of Physical Activity (IPAQ)

    Time frame: 4 weeks

    Physical activity assessment

  2. Goal orientation in exercise measure (GOEM)

    Time frame: 4 weeks

    Measurement of goal orientation in exercise

  3. Mini Nutritional Assessment

    Time frame: 4 weeks

    To evaluate the nutrition status of the patients

  4. The Problem Areas in Diabetes Scale (PADS)

    Time frame: 4 weeks

    PADS evaluates comprehensive diabetes evaluation. A total score is ranged between 0 - 100. Patients scoring 40 or higher may be at the level of "emotional burnout" and warrant special attention.

Sponsors and collaborators

Lead sponsor

Muğla Sıtkı Koçman University

Other

Registry information

Official study title

Effectiveness of Telehealth Program in Patients With Type 2 Diabetes: Randomized Controlled Study

Important dates

Study start
2022
Primary completion
2023
Study completion
2023
First posted
Jan 21, 2022
Registry last updated
Jun 15, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.